Barbara Cornblatt

Summary

Affiliation: Long Island Jewish Medical Center
Country: USA

Publications

  1. ncbi The schizophrenia prodrome: treatment and high-risk perspectives
    Barbara Cornblatt
    Department of Psychiatry Research, Hillside Hospital of the North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Schizophr Res 54:177-86. 2002
  2. ncbi Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia
    Todd Lencz
    Recognition and Prevention Program, Lake Success, NY 11042, USA
    Schizophr Res 68:37-48. 2004
  3. ncbi Spatial working memory deficits in adolescents at clinical high risk for schizophrenia
    Christopher W Smith
    Recognition and Prevention RAP Program, Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System NSLIJHS Glen Oaks, NY 11042, USA
    Schizophr Res 81:211-5. 2006
  4. ncbi Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America
    Tyrone D Cannon
    Department of Psychology, University of California, Los Angeles, 1285 Franz Hall, Los Angeles, CA 90095
    Arch Gen Psychiatry 65:28-37. 2008
  5. ncbi Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies
    Larry J Seidman
    Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Boston, USA
    Schizophr Bull 32:507-24. 2006
  6. ncbi The empirical status of the ultra high-risk (prodromal) research paradigm
    Tyrone D Cannon
    Department of Psychology, University of California, Los Angeles, CA, USA
    Schizophr Bull 33:661-4. 2007
  7. ncbi North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research
    Jean Addington
    Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada
    Schizophr Bull 33:665-72. 2007
  8. ncbi Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis
    Warrick J Brewer
    ORYGEN Research Centre and Early Psychosis Prevention and Intervention Centre, EPPIC, Department of Psychiatry, University of Melbourne, Australia
    Schizophr Bull 32:538-55. 2006
  9. ncbi Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities
    Lisa J Phillips
    PACE Clinic, ORYGEN Research Centre, Locked Bag 10, Parkville 8052, Victoria, Australia
    Br J Psychiatry Suppl 48:s33-44. 2005
  10. ncbi Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil
    James E Galvin
    Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA
    Alzheimer Dis Assoc Disord 22:30-8. 2008

Detail Information

Publications10

  1. ncbi The schizophrenia prodrome: treatment and high-risk perspectives
    Barbara Cornblatt
    Department of Psychiatry Research, Hillside Hospital of the North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Schizophr Res 54:177-86. 2002
    ..Depending upon clinical characteristics and phase of the prodrome, anti-depressants also appear highly effective...
  2. ncbi Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia
    Todd Lencz
    Recognition and Prevention Program, Lake Success, NY 11042, USA
    Schizophr Res 68:37-48. 2004
    ....
  3. ncbi Spatial working memory deficits in adolescents at clinical high risk for schizophrenia
    Christopher W Smith
    Recognition and Prevention RAP Program, Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System NSLIJHS Glen Oaks, NY 11042, USA
    Schizophr Res 81:211-5. 2006
    ..Although based on a small pilot study, the results strongly suggest that WM deficit may be a risk factor for psychosis...
  4. ncbi Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America
    Tyrone D Cannon
    Department of Psychology, University of California, Los Angeles, 1285 Franz Hall, Los Angeles, CA 90095
    Arch Gen Psychiatry 65:28-37. 2008
    ....
  5. ncbi Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies
    Larry J Seidman
    Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Boston, USA
    Schizophr Bull 32:507-24. 2006
    ..Ascertainment criteria for controls may markedly influence results and interpretation of group differences...
  6. ncbi The empirical status of the ultra high-risk (prodromal) research paradigm
    Tyrone D Cannon
    Department of Psychology, University of California, Los Angeles, CA, USA
    Schizophr Bull 33:661-4. 2007
    ....
  7. ncbi North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research
    Jean Addington
    Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada
    Schizophr Bull 33:665-72. 2007
    ....
  8. ncbi Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis
    Warrick J Brewer
    ORYGEN Research Centre and Early Psychosis Prevention and Intervention Centre, EPPIC, Department of Psychiatry, University of Melbourne, Australia
    Schizophr Bull 32:538-55. 2006
    ..Delineation of the relationship between specific cognitive ability and symptoms from data-driven approaches may improve our understanding of the role of cognition during psychosis onset...
  9. ncbi Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities
    Lisa J Phillips
    PACE Clinic, ORYGEN Research Centre, Locked Bag 10, Parkville 8052, Victoria, Australia
    Br J Psychiatry Suppl 48:s33-44. 2005
    ..Clinical and research focus has recently shifted from established psychotic disorders to first-episode psychosis and the prepsychotic phase of illness...
  10. ncbi Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil
    James E Galvin
    Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA
    Alzheimer Dis Assoc Disord 22:30-8. 2008
    ..Improved attention may have positive effects on cognitive and functional outcomes for AD patients, although this hypothesis requires further study and validation...